NERV - CEO at Minerva Neurosciences Acquires Company Stock Options Worth 100450 Shares | Benzinga
Remy Luthringer, CEO at Minerva Neurosciences (NASDAQ:NERV), reported a large acquisition of company stock options on October 5, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Luthringer, CEO at Minerva Neurosciences, a company in the Health Care sector, was just awarded stock options worth 100,450 shares of NERV. The options give Luthringer the right to buy the company's stock at $6.41 per share.
Minerva Neurosciences shares are trading up 7.72% at $6.7 at the time of this writing on Friday morning. Since the current price is $6.7, this makes Luthringer's 100,450 shares worth $673,015.